157 related articles for article (PubMed ID: 2233767)
1. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
Eisenhut S; Rascher W; Lang RE
Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB
J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397
[TBL] [Abstract][Full Text] [Related]
3. [Test with clonidine for diagnosing pheochromocytoma].
Wocial B; Chojnowski K; Chodakowska J; Feltynowski T; Lazecki D; Januszewicz W
Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):641-5. PubMed ID: 1845684
[TBL] [Abstract][Full Text] [Related]
4. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls.
Sjoberg RJ; Simcic KJ; Kidd GS
Arch Intern Med; 1992 Jun; 152(6):1193-7. PubMed ID: 1599347
[TBL] [Abstract][Full Text] [Related]
5. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma].
Stimpel M; Schürmeyer T; Ivens K; Wambach G; Volkmann HP; von zur Mühlen A
Dtsch Med Wochenschr; 1988 Jan; 113(4):130-4. PubMed ID: 3338391
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
[TBL] [Abstract][Full Text] [Related]
8. [The clonidine inhibition test: an aid in the diagnosis and postoperative therapeutic control in pheochromocytoma].
Schofer J; Tews A
Dtsch Med Wochenschr; 1985 Sep; 110(37):1403-7. PubMed ID: 4028993
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
Grouzmann E; Gicquel C; Plouin PF; Schlumberger M; Comoy E; Bohuon C
Cancer; 1990 Oct; 66(8):1833-5. PubMed ID: 2208039
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
[TBL] [Abstract][Full Text] [Related]
11. Clonidine suppression test--an evaluation of its diagnostic significance in hypertensive patients.
Choudhury R; Sagar S; Ganguly NK; Sharma BK; Khullar M
Indian Heart J; 1989; 41(3):162-7. PubMed ID: 2777299
[TBL] [Abstract][Full Text] [Related]
12. Clonidine suppression test for pheochromocytoma: examples of misleading results.
Taylor HC; Mayes D; Anton AH
J Clin Endocrinol Metab; 1986 Jul; 63(1):238-42. PubMed ID: 3711261
[TBL] [Abstract][Full Text] [Related]
13. [Estimation of clonidine test in differential diagnosis of pheochromocytoma from essential hypertension].
Nesović M; Cirić J; Zarković M; Popović V; Micić D; Mićić J
Srp Arh Celok Lek; 1990; 118(3-4):117-20. PubMed ID: 17977398
[TBL] [Abstract][Full Text] [Related]
14. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic hypotension following the clonidine suppression test for pheochromocytoma.
Given BD; Taylor T; Lilly LS; Dzau VJ
Arch Intern Med; 1983 Nov; 143(11):2195-6. PubMed ID: 6639244
[TBL] [Abstract][Full Text] [Related]
16. Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.
Bravo EL; Tarazi RC; Fouad FM; Vidt DG; Gifford RW
N Engl J Med; 1981 Sep; 305(11):623-6. PubMed ID: 7266587
[No Abstract] [Full Text] [Related]
17. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.
Mannelli M; De Feo ML; Maggi M; Pupilli C; Opocher G; Valenza T; Baldi E; Serio M
J Endocrinol Invest; 1987 Aug; 10(4):377-82. PubMed ID: 2890684
[TBL] [Abstract][Full Text] [Related]
18. Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case.
Dupont AG; Vanderniepen P; Gerlo E; Somers G; Vanhaelst L; in't Veld P; Gepts W; Sacre R; Six RO
J Endocrinol Invest; 1985 Apr; 8(2):153-6. PubMed ID: 4031382
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
[TBL] [Abstract][Full Text] [Related]
20. [The effect of clonidine on humoral factors in patients with arterial hypertension].
Poliak M; Horký K; Kopecká J; Gregorová I; Dvoráková J
Cas Lek Cesk; 1990 Mar; 129(10):301-5. PubMed ID: 2140296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
